Financing

ProCertus BioPharm secures $2.3M in financing

, an oncology-based pharmaceutical company, will...

2006: A great biotech financing year, unless you were going public!

Well folks, this is my last article of the year, and I have talked less about music this year than in years past, so my New Year's resolution for this column is bring back more music (hopefully something blue, rock, or folk-related). Part of the problem is that I simply have not gone to as many concerts this past year, or bought many new CDs (something else I will n...

Financing life science: The ongoing saga

Let's start with the Initial Public Offering (IPO) market, which is how many investors used to make money (those that had inve...

2005 was a tough year for U.S. biotech financing

Another research tool I have always found useful for this analysis is 's financial tracking information on the biotech industry. O...

The challenge of financing today's Midwest life science companies

There are now 48 Midwest VC groups in 16 states with combined capital of $2 billion under management that are affiliated with the ever...

Cellular Dynamics getting $2 million in Wisconsin financing

The company, (CDI), will receive a $1 million technology development grant and a $1 million technology development loan through the state Depa...

Conference will focus on financing of early-stage ventures

The event, to be held at the Monona Terrace in Madison, will run from Oct. 19-20. It is being organized by the Wisconsin Tech...

Financing of biotech companies so far in 2005: A Midwest odyssey

Just as you complete a round, you have to do two things: execute on the timely achievement of key milestones you identified for your new investors and look at the structuring of your next financing and where and who the money will come from. Most angel investors aren't repet...

2004 a banner year for biotech financing

does a great job of tracking U.S. biotech financing in all its shapes and forms (including funds flowing through due to partnerships with other biotech companies and Big Pharma). From its recent analysis, it would appear that 2004 was a very good year for biotech in almost all the financing categories. Lets take a look:<br...

Ralph Kauten on how to raise angel financing

But youll never get Ralph Kauten to admit that his success in high-tech entrepreneurship is somehow related to his own efforts. Ive been...

Seed-Stage Venture Financing

Seed-Stage Ventur...

Quintessence Secures Financing

MADISON, WI. - Quintessence Biosciences, Inc., a biotechnology company developing pharmaceutical products for use in research, has finalized a three million dollar financing deal. The majority of the funding, $2.3 million, was received from individual investors, and the remainder was borrowed from the Madison Development Corporation, Wisconsin Department of Commerce, and m2 Lease Funds, a private...